START FREE TRIAL

Oracle AI Spending Triggers Stock Crash In Wall Street Selloff

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Oracle (NYSE:ORCL) rarely surprises Wall Street. This time, it did. After reporting another quarter of strong cloud growth, Oracle’s stock fell sharply by more than 10% in a single session, a rarity for a low-beta company. The sell-off had little to do with demand. It had everything to do with timing, cash flow, and patience. Investors are struggling with one central issue: Oracle AI spending triggers stock crash because the returns are arriving much later than the bills.

Oracle is pouring billions into AI-focused data centers to serve customers like OpenAI, Meta, Nvidia, and xAI. Bookings are exploding. Backlog is massive. But profits are not showing up yet. Capital spending surged. Free cash flow turned deeply negative. Debt climbed. Management asked investors to wait until fiscal 2027 for meaningful revenue payoff. In today’s market, that wait feels long.

This tension explains the sharp drop in shares. Oracle AI spending triggers stock crash not because the strategy lacks logic, but because the near-term math looks uncomfortable. Below, we break down the four key forces behind the move, covering both the bullish long-term case and the bearish near-term risks.

Massive AI Backlog Strengthens Oracle’s Long-Term Cloud Position

The most important bullish point is demand. Oracle’s cloud infrastructure business is seeing growth that few legacy software companies ever achieve. Cloud infrastructure revenue rose more than 60% year over year. GPU-related revenue nearly tripled. Remaining performance obligations surged to over $520 billion. These are not small numbers. They signal real customer commitment, not trial projects.

Oracle’s positioning in AI infrastructure is now clear. It is not…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?

There are biotech stories that look obvious, and then...

This AI Infra Stock Could Anchor 6G And Edge Computing; PE Knows It’s MISPRICED!

There’s a reason SBA Communications (NASDAQ: SBAC) has suddenly...

Unilever’s $42 Billion Selloff Is Hiding a Much BIGGER Bet!

Unilever (NYSE: UL) did not just announce a deal—it...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that...

This “Broken” Biotech Just Forced Wall Street To Blink

Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle...

Related Articles

This AI Infra Stock Could Anchor 6G And Edge Computing; PE Knows It’s MISPRICED!

There’s a reason SBA Communications (NASDAQ: SBAC) has suddenly...

Unilever’s $42 Billion Selloff Is Hiding a Much BIGGER Bet!

Unilever (NYSE: UL) did not just announce a deal—it...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that...

This “Broken” Biotech Just Forced Wall Street To Blink

Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle...

Tesla Is Quietly Killing Its Own Cars—& What Comes Next Could Be MUCH BIGGER

For years, most investors have approached Tesla as an...

This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?

Boston Scientific (NYSE:BSX) spent the weekend putting forward what...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

For years, McCormick (NYSE:MKC) has been framed as one...
spot_img

Related Articles

Popular Categories

spot_imgspot_img